Nociceptin (1-11) (human, mouse, rat, porcine, bovine) 10 mg | ≥98% Cayman Chemical A peptide fragment of nociceptin and a NOP receptor 1 ligand More Information Supplier Page × Nociceptin (1-11) (human, mouse, rat, porcine, bovine)
A71915 (trifluoroacetate salt) 5 mg | ≥98% Cayman Chemical A GC-A antagonist More Information Supplier Page × A71915 (trifluoroacetate salt)
A71915 (trifluoroacetate salt) 25 mg | ≥98% Cayman Chemical A GC-A antagonist More Information Supplier Page × A71915 (trifluoroacetate salt)
A71915 (trifluoroacetate salt) 10 mg | ≥98% Cayman Chemical A GC-A antagonist More Information Supplier Page × A71915 (trifluoroacetate salt)
A71915 (trifluoroacetate salt) 1 mg | ≥98% Cayman Chemical A GC-A antagonist More Information Supplier Page × A71915 (trifluoroacetate salt)
ARV-471 5 mg | ≥98% Cayman Chemical A PROTAC that drives ER degradation More Information Supplier Page × ARV-471
ARV-471 10 mg | ≥98% Cayman Chemical A PROTAC that drives ER degradation More Information Supplier Page × ARV-471
ARV-471 1 mg | ≥98% Cayman Chemical A PROTAC that drives ER degradation More Information Supplier Page × ARV-471
Zopiclone Impurity B 500 mg | ≥95% Cayman Chemical A potential impurity found in commercial preparations of zopiclone More Information Supplier Page × Zopiclone Impurity B
Zopiclone Impurity B 5 g | ≥95% Cayman Chemical A potential impurity found in commercial preparations of zopiclone More Information Supplier Page × Zopiclone Impurity B
